Carna Biosciences, Inc., headquartered in Kobe, Japan, and established in 2003, is a clinical-stage biopharmaceutical company. Its core mission is to discover and advance innovative drug treatments specifically targeting critical unmet medical needs. Beyond its therapeutic pipeline, the company offers a comprehensive suite of specialized research reagents and tools.